Newron’s Steep Descent Accelerates as Evenamide Hopes Hinge on Conference Circuit
The sell-off in Newron Pharmaceuticals has shown no signs of letting up. Shares closed last Friday at €13.15, marking a ...
Tag: Newron SpA
Newron Secures Funding for Pivotal Schizophrenia Drug Trials
Italian biopharmaceutical firm Newron SpA has fortified its financial position, ensuring the advancement of its key clinical programs. The company ...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Walgreens Implements Deep Restructuring Following Private Buyout
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
